Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball +11 more
wiley +1 more source
Validity of PEN-FAST as a clinical decision tool in pregnant patients. [PDF]
You L +7 more
europepmc +1 more source
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth +8 more
wiley +1 more source
Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis. [PDF]
Islam N +43 more
europepmc +1 more source
ABSTRACT Mantle cell lymphoma (MCL) is a B‐cell malignancy with a chronically relapsing clinical course and pronounced genetic heterogeneity. To investigate the clonal dynamics underlying early disease relapse, we performed single‐cell RNA sequencing of paired tumor samples collected at diagnosis and at first relapse. Inference of copy number variants (
Dmitry Manakov +14 more
wiley +1 more source
Artificial Intelligence Exhibits Critical Blind Spots in Allergy Test Room Safety Design. [PDF]
Dumanoglu B +4 more
europepmc +1 more source
Epidemiology of Cancer‐Associated Venous Thromboembolism Across the United States
ABSTRACT Prior epidemiological studies on cancer‐associated venous thromboembolism (VTE) were limited by homogenous patient populations. We leverage Cosmos, a collaborative dataset of Epic electronic health record systems, to conduct an updated evaluation of cancer‐associated VTE in the United States (US).
Barbara D. Lam +7 more
wiley +1 more source
FoodCHOMP (Food Challenge-at HOme or in Medical Practice): a pilot multicentre randomised controlled trial evaluating home versus clinic-based food allergy challenges in low-risk adults-study protocol. [PDF]
Godsell J +8 more
europepmc +1 more source
Knowledge about occupational latex allergy amongst Thai nurses and student nurses. [PDF]
De Vocht, Frank +2 more
core +1 more source

